Subscribe
willy-barton
Willy Barton / shutterstock.com
21 May 2020Big PharmaRory O'Neill

Merck KGaA wins injunction after MSD trademark suit

The English High Court has finalised the terms of a trademark injunction against US pharmaceutical company  Merck Sharp & Dohme (MSD), in favour of German rival  Merck KGaA.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Monster falls short in Merck TM dispute
9 June 2020   Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Europe
DNA start-up refused UK trademark
15 October 2020   An Australian personalised genomics company has failed in its effort to obtain protection for its ‘MyDNA.life’ trademark in the UK.
Americas
MSD wins patent extension feud over post-surgery drug
15 June 2023   The three-year dispute revolved around proposed generic versions of a drug used to offset the effects of muscle relaxants | Pharma giant can retain patent until January 2026.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
Monster falls short in Merck TM dispute
9 June 2020   Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Europe
DNA start-up refused UK trademark
15 October 2020   An Australian personalised genomics company has failed in its effort to obtain protection for its ‘MyDNA.life’ trademark in the UK.
Americas
MSD wins patent extension feud over post-surgery drug
15 June 2023   The three-year dispute revolved around proposed generic versions of a drug used to offset the effects of muscle relaxants | Pharma giant can retain patent until January 2026.

More on this story

Big Pharma
Monster falls short in Merck TM dispute
9 June 2020   Monster Energy has failed to block a UK trademark filed by German pharmaceutical company Merck KGaA.
Europe
DNA start-up refused UK trademark
15 October 2020   An Australian personalised genomics company has failed in its effort to obtain protection for its ‘MyDNA.life’ trademark in the UK.
Americas
MSD wins patent extension feud over post-surgery drug
15 June 2023   The three-year dispute revolved around proposed generic versions of a drug used to offset the effects of muscle relaxants | Pharma giant can retain patent until January 2026.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility